Pfizer Inc.
PFEPfizer Inc. (PFE) is a Healthcare company that currently yields 7.15% — historically undervalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $24.29 and the overvaluation threshold at $41.62. Pfizer Inc. holds a quality score of 48/100 (Average), reflecting 14 consecutive years of dividend growth with a 131% payout ratio. The 5-year dividend CAGR stands at 3.6%.
PFE Dividend Yield History — Weiss Valuation
Distance to undervalued
In undervalued territory
Price sits 1.0% below the Weiss buy zone ceiling
The current yield already clears the historical undervaluation threshold. The next question is whether the dividend quality and payout profile deserve that higher yield.
Zone ceiling
$24.29
Current yield
7.15%
Research checklist
What to clear before buying the yield
Updated Jul 9, 2026
Dividend durability
14YLong dividend history supports a deeper look.
Earnings payout
131%Coverage deserves a closer look in filings.
Cash payout
79%Free cash flow coverage supports the payment.
Dividend growth
3.6%Recent growth adds income compounding potential.
What changed
What changed since the last update
2026-07-08 → 2026-07-09
No major change in signal, yield, price, quality, or payout since the last update.
Why Now?
Pfizer Inc. is trading near its historical undervaluation band.
Current yield 7.2% vs historical max 7.0% (102% of maximum).
14 consecutive years without a dividend cut.
Elevated payout ratio of 131%.
What matters now
Read the signal before the headline yield
Valuation is the invitation here: the yield is elevated versus its own history.
The 48/100 quality score says the headline yield needs extra skepticism.
The earnings payout ratio is above 100%, so coverage is the first risk to unpack.
PFE Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$741
Year 10 Income
$2,135
Yield on Cost
23.52%
Total Income
$13,091
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
Track actual vs. projected
See what PFE dividends you actually received with Sharesight
Dividend income log · Yield on cost · DRIP cost basis · Tax reports
More research
Full price history & technical analysis
TradingView ↗Fundamentals, valuation & analyst ratings
FinViz ↗Moat rating & analyst fair value
Morningstar ↗Track dividends received & tax reports
Sharesight ↗PFE Dividend Quality Score
Quality Score
Average
Key Metrics
PFE is historically undervalued. Ready to add it to your portfolio?
Start investing on eToro →DividendVisual may earn a commission if you open an account via this link, at no cost to you. Capital at risk. Not financial advice.
In-depth analysis
→ PFE Dividend Analysis Article